We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
National Diabetes Inpatient Audit (NaDIA) - 2018
Audit, Open data- Publication Date:
- 9 May 2019
- Geographic Coverage:
- England, Wales
- Geographical Granularity:
- Country, NHS Trusts, Hospital Trusts
Summary
The National Diabetes Inpatient Audit (NaDIA) measures the quality of diabetes care provided to people with diabetes while they are admitted to hospital whatever the cause, and aims to support quality improvement. Data is collected and submitted by hospital staff in England and Wales. The NaDIA audit is part of the National Diabetes Audit (NDA) portfolio within the National Clinical Audit and Patient Outcomes Programme (NCAPOP), commissioned by the Healthcare Quality Improvement Partnership (HQIP).
In September 2018 NaDIA undertook a snapshot audit of hospital characteristics in England and Wales.
In addition to the snapshot audit the collection of NaDIA-Harms began in England in 2018; this is a new continuous collection of serious inpatient harms that only affect people with diabetes. The NaDIA-Harms 2018 report can be found here - http://digital.nhs.uk/pubs/nadia2018
Key Facts
Participation in NaDIA Hospital Characteristics dipped in 2018 with over 20 sites failing to return a survey
Inpatient staffing levels for almost all diabetes professions have increased substantially since 2017
One fifth of hospitals still have no diabetes inpatient specialist nurses (DISNs)
Use of electronic prescribing and electronic patient records continues to rise slowly. Almost 65% of NaDIA sites still do not fully utilise electronic prescribing technology